Using germline variants to estimate glioma and subtype risks.
Eckel-Passow JE, Decker PA, Kosel ML, Kollmeyer TM, Molinaro AM, Rice T, Caron AA, Drucker KL, Praska CE, Pekmezci M, Hansen HM, McCoy LS, Bracci PM, Erickson BJ, Lucchinetti CF, Wiemels JL, Wiencke JK, Bondy ML, Melin B, Burns TC, Giannini C, Lachance DH, Wrensch MR, Jenkins RB.
Eckel-Passow JE, et al. Among authors: wrensch mr.
Neuro Oncol. 2019 Mar 18;21(4):451-461. doi: 10.1093/neuonc/noz009.
Neuro Oncol. 2019.
PMID: 30624711
Free PMC article.